[go: up one dir, main page]

WO2023211634A1 - Applicator with cartridges configured to deliver plasma energies for skin treatment - Google Patents

Applicator with cartridges configured to deliver plasma energies for skin treatment Download PDF

Info

Publication number
WO2023211634A1
WO2023211634A1 PCT/US2023/017186 US2023017186W WO2023211634A1 WO 2023211634 A1 WO2023211634 A1 WO 2023211634A1 US 2023017186 W US2023017186 W US 2023017186W WO 2023211634 A1 WO2023211634 A1 WO 2023211634A1
Authority
WO
WIPO (PCT)
Prior art keywords
dispensing device
applicator
formula
plasma treatment
skin care
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2023/017186
Other languages
French (fr)
Inventor
Casey BARBARINO
Gregoire CHARRAUD
Rafael FELICIANO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/733,200 external-priority patent/US20230346104A1/en
Priority claimed from FR2206222A external-priority patent/FR3136953B1/en
Application filed by LOreal SA filed Critical LOreal SA
Publication of WO2023211634A1 publication Critical patent/WO2023211634A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/90Identification means for patients or instruments, e.g. tags
    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45DHAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D34/00Containers or accessories specially adapted for handling liquid toiletry or cosmetic substances, e.g. perfumes
    • A45D34/04Appliances specially adapted for applying liquid, e.g. using roller or ball
    • A45D34/041Appliances specially adapted for applying liquid, e.g. using roller or ball using a roller, a disc or a ball
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/90Identification means for patients or instruments, e.g. tags
    • A61B90/98Identification means for patients or instruments, e.g. tags using electromagnetic means, e.g. transponders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0616Skin treatment other than tanning
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • A61B2018/00583Coblation, i.e. ablation using a cold plasma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00994Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combining two or more different kinds of non-mechanical energy or combining one or more non-mechanical energies with ultrasound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/328Applying electric currents by contact electrodes alternating or intermittent currents for improving the appearance of the skin, e.g. facial toning or wrinkle treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0651Diodes

Definitions

  • a skin care system including a dispensing device configured to administer a light therapy and a plasma treatment, and an applicator configured to apply a formula, including a reservoir configured to hold the formula, a roller ball configured to apply the formula, an attachment configured to attach the cartridge to the dispensing device, and a microcontroller configured to direct the dispensing device to apply the plasma treatment is disclosed.
  • a method of administering multiple skin treatments using the skin care system, the method including selecting an applicator filled with a formula, placing the applicator into the dispensing device, identifying a plasma treatment to apply based on the applicator, applying the formula, administering light therapy, and administering the plasma treatment is disclosed.
  • FIGURE 1 is an example applicator, in accordance with the present technology
  • FIGURE 2 is an example cross-section of an applicator, in accordance with the present technology
  • FIGURE 3 is an example dispensing device, in accordance with the present technology
  • FIGURE 4 is an example method of using a skin care system, in accordance with the present technology.
  • an applicator with a microcontroller that is capable of instructing a dispensing device to administer a plasma treatment while applying both formula and light therapy.
  • the plasma treatment is a cold plasma treatment.
  • the plasma treatment is administered through an electrode and one or more wires.
  • the dispensing device applies high voltage through the one or more wires to the electrode to generate plasma as a roller ball on the applicator rolls over a surface.
  • FIG. 1 is an example applicator, in accordance with the present technology.
  • the applicator 100 may include a roller ball 110, and an attachment 120.
  • the roller ball 110 may be configured to distribute and apply a formula located a reservoir inside the applicator 100 (as shown in FIG. 2).
  • the roller ball 110 is plastic, but in other embodiments, the roller ball 110 may be glass or metal.
  • the applicator 100 also includes an attachment 120 configured to secure the applicator 100 into a dispensing device, such as the dispensing device 200 in FIG. 3. While the attachment 120 is illustrated as a disk shaped to couple to a dispensing device, the attachment 120 may take any form capable of securing the applicator to a dispensing device including a threaded attachment, a magnet, or an attachment configured to snap into the dispensing device. In some embodiments, the attachment 120 is clear so that the dispensing device is visible through the attachment.
  • the applicator 100 can be placed inside a dispensing device (as shown in FIG. 3) and secured to the dispensing device with the attachment 120.
  • the roller ball 110 can be rolled over a surface, such as a user’s skin, to apply a formula.
  • FIG. 2 is an example cross-section of an applicator 100, in accordance with the present technology.
  • the applicator 100 may include a roller ball 110, an attachment 120, a reservoir 130 configured to hold a formula 140, a piston 150, a microcontroller 160, and a processor 170.
  • the applicator further includes an electrode 180, and one or more wires, 190a, 190b.
  • the reservoir 130 is located inside the applicator 100, and is configured to hold a formula 140.
  • the formula 140 is a skin care formula.
  • the skin care formula is a moisturizer, a toner, an acne treatment, a wrinkle treatment, fine line treatment, or a cosmetic. As the roller ball 110 rolls, formula 140 from the reservoir 130 is applied to a surface.
  • the applicator 100 further includes a piston 150 configured to push the formula 140 towards the roller ball 110 as the formula is applied.
  • the piston 150 is directed by circuitry on a dispensing device or on the applicator itself to push the formula 140.
  • the applicator 100 includes a microcontroller 160 configured to identify the type of formula 140 inside the applicator 100 to a dispensing device.
  • the microcontroller 160 further identifies the type of treatment the applicator should apply, /. ⁇ ., the type of plasma treatment that should be applied with the type of formula 140.
  • the plasma treatment is cold plasma treatment.
  • the plasma treatment is continuous.
  • the plasma treatment is pulsed.
  • the plasma treatment is applied for a specific time amount, such as one minute, or five minutes.
  • the applicator stops administering plasma treatment when the specific time amount has elapsed.
  • the microcontroller 160 may also be used to identify any number of things about the formula 140 or applicator 100, including the amount of formula 140 inside the applicator 100, the expiration date of the formula 140 inside the applicator 100, or when to replace the applicator 100.
  • the applicator 100 further includes an electrode 180, and one or more wires 190A, 190B configured to administer a plasma treatment.
  • the electrode 180 is the attachment 120.
  • the electrode 180 is made of a conductive material.
  • the electrode 180 is located inside the attachment 120 (as shown in FIG. 1) and is merely a component of the attachment 120.
  • one or more wires 190A, 190B connect to the electrode 180 to generate the plasma.
  • high voltage is applied to the one or more wires 190 A, 190B by the applicator.
  • high voltage is applied to the one or more wires 190A, 190B from a dispensing device (such as dispensing device 200 in FIG. 3). In some embodiments, the high voltage is above 25 kV. In some embodiments, the high voltage is above 50 kV. In operation, high voltage can be applied to the one or more wires 190 A, 190B and to the electrode 180 to generate plasma while the user rolls the applicator 100 on their skin.
  • FIG. 3 is an example dispensing device, in accordance with the present technology.
  • the applicator 100 can be attached to a dispensing device 200.
  • the dispensing device includes an end 210, one or more light sources 220a, 220b, an actuator 230, and a contactless reader 240.
  • the applicator 100 connects to the dispensing device 200.
  • the dispensing device 200 includes an end 210.
  • the end 210 may be configured to be seen through the attachment 120 on the applicator 100.
  • the end 210 includes one or more light sources 220a, 220b configured to administer light therapy to a surface while the formula 140 is being applied.
  • the one or more light sources 220a, 220b are LEDs. In some embodiments, there are only two light sources 220a, 220b on the dispensing device. In some embodiments, a first light source 220a is configured to administer light therapy in a first wavelength. In some embodiments, a second light source 220b is configured to administer light therapy in a second wavelength. In some embodiments, the light therapy in the first wavelength and the light therapy in the second wavelength are administered simultaneously. In some embodiments, the light therapy and applying the formula happen simultaneously. In some embodiments, there are one or more light sources 220a, 220b in a ring, located around the end 210 of the dispensing device 200.
  • the dispensing device 200 includes one or more actuators 230. While the actuator 230 is illustrated as a button, in some embodiments, the actuator 230 may be a switch, a capacitive touch type button, a dial, or the like. The actuator 230 may be configured to begin the administration of light therapy, to apply the formula, to control the plasma treatment, or all three. In some embodiments, the dispensing device 200 also includes a contact-less chip reader 240 to read the microcontroller 160 on the applicator 100.
  • a user may place an applicator 100 into the dispensing device 200.
  • the actuator 230 is actuated, the formula is applied, the light therapy is administered, or both, simultaneously.
  • a user may then apply the formula with the applicator 100.
  • the plasma treatment can be administered at the same time as the light therapy and applying the formula.
  • FIG. 4 is an example method 400 of using a skin care system, in accordance with the present technology.
  • an applicator is selected having a specific formula and configured to direct the applicator and/or the dispensing device to administer a specific plasma treatment.
  • the plasma treatment is cold plasma treatment.
  • the plasma treatment is continuous.
  • the plasma treatment is pulsed.
  • the plasma treatment is applied for a specific time amount, such as one minute, or five minutes.
  • the applicator stops administering plasma treatment when the specific time amount has elapsed.
  • the applicator further directs the applicator and/or the dispensing device to administer the plasma treatment at a specific voltage.
  • the applicator is attached to the dispensing device.
  • the applicator is attached to the dispensing device with an attachment.
  • the applicator is clear to allow one or more light sources on the dispensing device to emit light through the attachment.
  • the applicator slides, clicks, or connects into the dispensing device.
  • the applicator attaches to the dispensing device with a threaded connection or a magnet.
  • the dispensing device reads the microprocessor (or contactless chip) on the applicator with a contactless reader.
  • the microprocessor on the applicator identifies the type of formula, the type of plasma treatment to administer, the lifetime of the applicator, the amount of formula inside the applicator, or a combination thereof.
  • formula is applied as the roller ball is rolled along a surface.
  • the surface is a user’s face.
  • the surface may be any portion of the user’s skin.
  • the dispensing device includes an actuator configured to begin both the application of the formula and the administration of the light therapy.
  • the dispensing device includes two or more light sources configured to administer the light therapy.
  • the dispensing device is configured to deliver two or more types of light therapy, either one at a time, or simultaneously.
  • one light source is configured to administer a first light therapy
  • another light source is configured to administer a second light therapy.
  • the first light therapy may include emitting a first light at a first wavelength
  • the second light therapy may include emitting a second light at a second wavelength.
  • the plasma treatment is applied with the applicator.
  • blocks 440, 450, and 460 occur simultaneously.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Biophysics (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A skin care system including a dispensing device configured to administer a light therapy and a plasma treatment, and an applicator configured to apply a formula, comprising a reservoir configured to hold the formula, a roller ball configured to apply the formula, an attachment configured to attach the cartridge to the dispensing device, and a microcontroller configured to direct the dispensing devices to apply the plasma treatment.

Description

APPLICATOR WITH CARTRIDGES CONFIGURED TO DELIVER PLASMA ENERGIES FOR SKIN TREATMENT
CROSS-REFERENCES TO RELATED APPLICATIONS
This application claims the benefit of U.S. Patent Application No. 17/733200, filed on April 29, 2022; and also claims the benefit of French Patent Application No. 2206222, filed on June 23, 2022; the contents of all of which are hereby incorporated by reference in their entirety.
SUMMARY
This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This summary is not intended to identify key features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
In one aspect, a skin care system including a dispensing device configured to administer a light therapy and a plasma treatment, and an applicator configured to apply a formula, including a reservoir configured to hold the formula, a roller ball configured to apply the formula, an attachment configured to attach the cartridge to the dispensing device, and a microcontroller configured to direct the dispensing device to apply the plasma treatment is disclosed.
In another aspect, a method of administering multiple skin treatments, using the skin care system, the method including selecting an applicator filled with a formula, placing the applicator into the dispensing device, identifying a plasma treatment to apply based on the applicator, applying the formula, administering light therapy, and administering the plasma treatment is disclosed.
DESCRIPTION OF THE DRAWINGS
The foregoing aspects and many of the attendant advantages of this invention will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein:
FIGURE 1 is an example applicator, in accordance with the present technology;
FIGURE 2 is an example cross-section of an applicator, in accordance with the present technology; FIGURE 3 is an example dispensing device, in accordance with the present technology; and
FIGURE 4 is an example method of using a skin care system, in accordance with the present technology.
DETAILED DESCRIPTION
While illustrative embodiments have been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the invention.
Described herein is an applicator with a microcontroller that is capable of instructing a dispensing device to administer a plasma treatment while applying both formula and light therapy. In some embodiments, the plasma treatment is a cold plasma treatment. In some embodiments, the plasma treatment is administered through an electrode and one or more wires. In some embodiments, the dispensing device applies high voltage through the one or more wires to the electrode to generate plasma as a roller ball on the applicator rolls over a surface.
FIG. 1 is an example applicator, in accordance with the present technology. The applicator 100 may include a roller ball 110, and an attachment 120.
The roller ball 110 may be configured to distribute and apply a formula located a reservoir inside the applicator 100 (as shown in FIG. 2). In some embodiments, the roller ball 110 is plastic, but in other embodiments, the roller ball 110 may be glass or metal.
In some embodiments, the applicator 100 also includes an attachment 120 configured to secure the applicator 100 into a dispensing device, such as the dispensing device 200 in FIG. 3. While the attachment 120 is illustrated as a disk shaped to couple to a dispensing device, the attachment 120 may take any form capable of securing the applicator to a dispensing device including a threaded attachment, a magnet, or an attachment configured to snap into the dispensing device. In some embodiments, the attachment 120 is clear so that the dispensing device is visible through the attachment.
In operation, the applicator 100 can be placed inside a dispensing device (as shown in FIG. 3) and secured to the dispensing device with the attachment 120. The roller ball 110 can be rolled over a surface, such as a user’s skin, to apply a formula.
FIG. 2 is an example cross-section of an applicator 100, in accordance with the present technology. The applicator 100 may include a roller ball 110, an attachment 120, a reservoir 130 configured to hold a formula 140, a piston 150, a microcontroller 160, and a processor 170. In some embodiments, the applicator further includes an electrode 180, and one or more wires, 190a, 190b.
In some embodiments, the reservoir 130 is located inside the applicator 100, and is configured to hold a formula 140. In some embodiments, the formula 140 is a skin care formula. In some embodiments, the skin care formula is a moisturizer, a toner, an acne treatment, a wrinkle treatment, fine line treatment, or a cosmetic. As the roller ball 110 rolls, formula 140 from the reservoir 130 is applied to a surface.
In some embodiments, the applicator 100 further includes a piston 150 configured to push the formula 140 towards the roller ball 110 as the formula is applied. In some embodiments, the piston 150 is directed by circuitry on a dispensing device or on the applicator itself to push the formula 140.
In some embodiments, the applicator 100 includes a microcontroller 160 configured to identify the type of formula 140 inside the applicator 100 to a dispensing device. In some embodiments, the microcontroller 160 further identifies the type of treatment the applicator should apply, /.< ., the type of plasma treatment that should be applied with the type of formula 140. In some embodiments, the plasma treatment is cold plasma treatment. In some embodiments, the plasma treatment is continuous. In some embodiments, the plasma treatment is pulsed. In some embodiments, the plasma treatment is applied for a specific time amount, such as one minute, or five minutes. In some embodiments, the applicator stops administering plasma treatment when the specific time amount has elapsed. The microcontroller 160 may also be used to identify any number of things about the formula 140 or applicator 100, including the amount of formula 140 inside the applicator 100, the expiration date of the formula 140 inside the applicator 100, or when to replace the applicator 100.
In some embodiments, the applicator 100 further includes an electrode 180, and one or more wires 190A, 190B configured to administer a plasma treatment. In some embodiments, the electrode 180 is the attachment 120. In some embodiments, the electrode 180 is made of a conductive material. In some embodiments, the electrode 180 is located inside the attachment 120 (as shown in FIG. 1) and is merely a component of the attachment 120. In some embodiments, one or more wires 190A, 190B connect to the electrode 180 to generate the plasma. In some embodiments, high voltage is applied to the one or more wires 190 A, 190B by the applicator. In some embodiments, high voltage is applied to the one or more wires 190A, 190B from a dispensing device (such as dispensing device 200 in FIG. 3). In some embodiments, the high voltage is above 25 kV. In some embodiments, the high voltage is above 50 kV. In operation, high voltage can be applied to the one or more wires 190 A, 190B and to the electrode 180 to generate plasma while the user rolls the applicator 100 on their skin.
FIG. 3 is an example dispensing device, in accordance with the present technology. In some embodiments, the applicator 100 can be attached to a dispensing device 200. In some embodiments, the dispensing device includes an end 210, one or more light sources 220a, 220b, an actuator 230, and a contactless reader 240. In some embodiments, the applicator 100 connects to the dispensing device 200.
In some embodiments, the dispensing device 200 includes an end 210. The end 210 may be configured to be seen through the attachment 120 on the applicator 100. In some embodiments, the end 210 includes one or more light sources 220a, 220b configured to administer light therapy to a surface while the formula 140 is being applied.
In some embodiments, the one or more light sources 220a, 220b are LEDs. In some embodiments, there are only two light sources 220a, 220b on the dispensing device. In some embodiments, a first light source 220a is configured to administer light therapy in a first wavelength. In some embodiments, a second light source 220b is configured to administer light therapy in a second wavelength. In some embodiments, the light therapy in the first wavelength and the light therapy in the second wavelength are administered simultaneously. In some embodiments, the light therapy and applying the formula happen simultaneously. In some embodiments, there are one or more light sources 220a, 220b in a ring, located around the end 210 of the dispensing device 200.
In some embodiments, the dispensing device 200 includes one or more actuators 230. While the actuator 230 is illustrated as a button, in some embodiments, the actuator 230 may be a switch, a capacitive touch type button, a dial, or the like. The actuator 230 may be configured to begin the administration of light therapy, to apply the formula, to control the plasma treatment, or all three. In some embodiments, the dispensing device 200 also includes a contact-less chip reader 240 to read the microcontroller 160 on the applicator 100.
In operation, a user may place an applicator 100 into the dispensing device 200. When the actuator 230 is actuated, the formula is applied, the light therapy is administered, or both, simultaneously. A user may then apply the formula with the applicator 100. Additionally, the plasma treatment can be administered at the same time as the light therapy and applying the formula.
FIG. 4 is an example method 400 of using a skin care system, in accordance with the present technology.
In block 410, an applicator is selected having a specific formula and configured to direct the applicator and/or the dispensing device to administer a specific plasma treatment. In some embodiments, the plasma treatment is cold plasma treatment. In some embodiments, the plasma treatment is continuous. In some embodiments, the plasma treatment is pulsed. In some embodiments, the plasma treatment is applied for a specific time amount, such as one minute, or five minutes. In some embodiments, the applicator stops administering plasma treatment when the specific time amount has elapsed. In some embodiments, the applicator further directs the applicator and/or the dispensing device to administer the plasma treatment at a specific voltage.
In block 420, the applicator is attached to the dispensing device. In some embodiments, the applicator is attached to the dispensing device with an attachment. In some embodiments, the applicator is clear to allow one or more light sources on the dispensing device to emit light through the attachment. In some embodiments, the applicator slides, clicks, or connects into the dispensing device. In some embodiments, the applicator attaches to the dispensing device with a threaded connection or a magnet.
In block 430, the dispensing device reads the microprocessor (or contactless chip) on the applicator with a contactless reader. In some embodiments, the microprocessor on the applicator identifies the type of formula, the type of plasma treatment to administer, the lifetime of the applicator, the amount of formula inside the applicator, or a combination thereof.
In block 440, formula is applied as the roller ball is rolled along a surface. In some embodiments, the surface is a user’s face. In some embodiments, the surface may be any portion of the user’s skin.
In block 450, light therapy is applied with the dispensing device. In some embodiments, the dispensing device includes an actuator configured to begin both the application of the formula and the administration of the light therapy. In some embodiments, the dispensing device includes two or more light sources configured to administer the light therapy. In some embodiments, the dispensing device is configured to deliver two or more types of light therapy, either one at a time, or simultaneously. In such embodiments, one light source is configured to administer a first light therapy, and another light source is configured to administer a second light therapy. In some embodiments, the first light therapy may include emitting a first light at a first wavelength, and the second light therapy may include emitting a second light at a second wavelength.
In block 460, the plasma treatment is applied with the applicator. In some embodiments, blocks 440, 450, and 460 occur simultaneously.
In block 470, the method ends.

Claims

CLAIMS The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. A skin care system comprising: a dispensing device configured to administer a light therapy and a plasma treatment; and an applicator configured to apply a formula, comprising: a reservoir configured to hold the formula, a roller ball configured to apply the formula, an attachment configured to attach the cartridge to the dispensing device, and a microcontroller configured to direct the dispensing device to apply the plasma treatment.
2. The skin care system of Claim 1, wherein the light therapy and the plasma treatment are administered simultaneously with the application of the formula.
3. The skin care system of Claim 1 or Claim 2, wherein the dispensing device is configured to apply two or more wavelengths of light therapy simultaneously.
4. The skin care system of any one of Claims 1-3, wherein the dispensing device administers light therapy through one or more light sources.
5. The skin care system of Claim 4, wherein the one or more light sources are a ring of LEDs around a top of the dispensing device.
6. The skin care system of Claim 4 or Claim 5, wherein the applicator further comprises a clear attachment so that the light from the one or more light sources on the dispensing device can pass through the attachment to administer the light therapy.
7. The skin care system of any one of Claims 1-6, wherein the applicator further comprises an electrode configured to create plasma on contact with a surface.
8. The skin care system of Claim 7, wherein the attachment is the electrode.
9. The skin care system of Claim 7 or Claim 8, wherein the applicator further comprises a wire connecting the electrode to the dispensing device.
10. The skin care system of Claim 9, wherein the dispensing device is further configured to pass high voltage through the wire and to the electrode.
11. A method of administering multiple skin treatments, using the device of Claim 1, the method comprising: selecting an applicator filled with a formula; placing the applicator into the dispensing device; identifying a plasma treatment to apply based on the applicator; applying the formula; administering light therapy; and administering the plasma treatment.
12. The method of Claim 11, wherein applying of the formula, the administering the light therapy, and administering the plasma treatment is done simultaneously.
13. The method of Claim 11 or Claim 12, wherein the dispensing device administers light therapy through one or more light sources.
14. The method of Claim 13, wherein the one or more light sources are a ring of LEDs around a top of the dispensing device.
15. The method of any one of Claims 11-14, wherein the method further comprises identifying the formula in the applicator with the dispensing device.
PCT/US2023/017186 2022-04-29 2023-03-31 Applicator with cartridges configured to deliver plasma energies for skin treatment Ceased WO2023211634A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17/733,200 2022-04-29
US17/733,200 US20230346104A1 (en) 2022-04-29 2022-04-29 Applicator with cartridges configured to deliver plasma energies for skin treatment
FR2206222A FR3136953B1 (en) 2022-06-23 2022-06-23 Applicator with capsules designed to deliver plasma energies for skin treatment
FRFR2206222 2022-06-23

Publications (1)

Publication Number Publication Date
WO2023211634A1 true WO2023211634A1 (en) 2023-11-02

Family

ID=86185251

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2023/017186 Ceased WO2023211634A1 (en) 2022-04-29 2023-03-31 Applicator with cartridges configured to deliver plasma energies for skin treatment

Country Status (1)

Country Link
WO (1) WO2023211634A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2949650A1 (en) * 2009-09-04 2011-03-11 Oreal Device, useful to treat human perspiration and body odors preferably underarm odors, comprises support receiving deodorant and/or antiperspirant product, where the support further receives source of biocide gas (ozone)
WO2015089425A1 (en) * 2013-12-13 2015-06-18 Guided Therapy Systems, Llc System and method for non-invasive treatment with improved efficiency
US20150327653A1 (en) * 2012-12-15 2015-11-19 In Derm Applicator and Capsule for such Applicator
US20180008333A1 (en) * 2016-07-08 2018-01-11 Seok JIN Skin care apparatus using plasma and near infrared ray
US20180168318A1 (en) * 2015-08-18 2018-06-21 L'oreal Connected photo-activatable formulation applicator
KR101970644B1 (en) * 2017-11-22 2019-08-13 주식회사 하이로닉 Multifunctional skin treatment device for enhancement of transdermal delivery
US20200038673A1 (en) * 2018-07-31 2020-02-06 L'oreal Cold plasma generating devices, systems, and methods

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2949650A1 (en) * 2009-09-04 2011-03-11 Oreal Device, useful to treat human perspiration and body odors preferably underarm odors, comprises support receiving deodorant and/or antiperspirant product, where the support further receives source of biocide gas (ozone)
US20150327653A1 (en) * 2012-12-15 2015-11-19 In Derm Applicator and Capsule for such Applicator
WO2015089425A1 (en) * 2013-12-13 2015-06-18 Guided Therapy Systems, Llc System and method for non-invasive treatment with improved efficiency
US20180168318A1 (en) * 2015-08-18 2018-06-21 L'oreal Connected photo-activatable formulation applicator
US20180008333A1 (en) * 2016-07-08 2018-01-11 Seok JIN Skin care apparatus using plasma and near infrared ray
KR101970644B1 (en) * 2017-11-22 2019-08-13 주식회사 하이로닉 Multifunctional skin treatment device for enhancement of transdermal delivery
US20200038673A1 (en) * 2018-07-31 2020-02-06 L'oreal Cold plasma generating devices, systems, and methods

Similar Documents

Publication Publication Date Title
JP7359879B2 (en) Combined photoactivatable formulation applicator
US11642520B2 (en) Electronic skin rejuvenating device and methods of use
US5304207A (en) Electrostimulator with light emitting device
CN104168952B (en) fluid dispenser
CN110603074B (en) Sinus treatment device with adaptive circuitry
WO2023211656A1 (en) Applicator with cartridges configured to deliver vibration for skin treatment
US20040039328A1 (en) Iontophoretic drug delivery electrodes and method
JP2018134535A (en) Dermatological medical device
KR20070065252A (en) Skin treatment using benefit agents and devices
JPS6055949A (en) Eye dropper with light source
CA2413806A1 (en) Electrokinetic delivery device
CN109310874A (en) Iontophoresis device, iontophoresis method, and skin beauty device including the same
KR20180134624A (en) Face mask having multi - wavelength light part
US20230346104A1 (en) Applicator with cartridges configured to deliver plasma energies for skin treatment
WO2023211634A1 (en) Applicator with cartridges configured to deliver plasma energies for skin treatment
WO2023211657A1 (en) Applicator with cartridges configured to deliver microcurrent for skin treatment
US20230347122A1 (en) Applicator with cartridges configured to deliver microcurrent for skin treatment
US12089716B2 (en) Applicator with cartridges configured to deliver vibration for skin treatment
EP4595807A1 (en) Roller ball applicator with contactless piston to dispense formula
KR20190128960A (en) Skin care device for injection of ionized ampoule
KR102348416B1 (en) skin care device
Ravichandran et al. Electrotactile proprioception training improves finger control accuracy and potential mechanism is proprioceptive recalibration
KR101939285B1 (en) Wrist protecting pad using near infrared ray
KR101712654B1 (en) Device for skin beauty using galvanic current
CN100386118C (en) Adhesive tape used to treat the human body

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23719575

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 23719575

Country of ref document: EP

Kind code of ref document: A1